|Publication Type||Journal Article|
|Year of Publication||2020|
|Authors||Brook, B, Harbeson, DJ, Shannon, CP, Cai, B, He, D, Ben-Othman, R, Francis, F, Huang, J, Varankovich, N, Liu, A, Bao, W, Bjerregaard-Andersen, M, Schaltz-Buchholzer, F, Sanca, L, Golding, CN, Larsen, KLindberg, Levy, O, Kampmann, B, Tan, R, Charles, A, Wynn, JL, Shann, F, Aaby, P, Benn, CS, Tebbutt, SJ, Kollmann, TR, Amenyogbe, N|
|Corporate Authors||EPIC Consortium|
|Journal||Sci Transl Med|
|Date Published||2020 May 06|
Death from sepsis in the neonatal period remains a serious threat for millions. Within 3 days of administration, bacille Calmette-Guérin (BCG) vaccination can reduce mortality from neonatal sepsis in human newborns, but the underlying mechanism for this rapid protection is unknown. We found that BCG was also protective in a mouse model of neonatal polymicrobial sepsis, where it induced granulocyte colony-stimulating factor (G-CSF) within hours of administration. This was necessary and sufficient to drive emergency granulopoiesis (EG), resulting in a marked increase in neutrophils. This increase in neutrophils was directly and quantitatively responsible for protection from sepsis. Rapid induction of EG after BCG administration also occurred in three independent cohorts of human neonates.
|Alternate Journal||Sci Transl Med|